HansBiomed Corporation (KOSDAQ: 042520)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,330
+680 (7.05%)
Sep 12, 2024, 10:10 AM KST

HansBiomed Company Description

HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix.

It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution.

The company was formerly known as Hans Medical Corp. and changed its name to HansBiomed Corporation in June 2000.

The company was founded in 1990 and is headquartered in Seoul, South Korea.

HansBiomed Corporation
Country South Korea
Founded 1990
Industry Biological Products, Except Diagnostic Substances
Employees 127
CEO Guen Young Kim

Contact Details

Address:
7, Jeongui-ro 8-gil
Seoul, 05836
South Korea
Phone 82 2 466 2266
Website hansbiomed.com

Stock Details

Ticker Symbol 042520
Exchange KOSDAQ
Fiscal Year October - September
Reporting Currency KRW
SIC Code 2836

Key Executives

Name Position
Guen Young Kim Chief Executive Officer
Seok-Bae Oh Chief Financial Officer